- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa launches its first patient record product in Europe
Agfa formally introduced its medAr electronic patient record system at the European Congress of Radiology as part of the company’s strategy to move beyond the radiology industry and into the healthcare enterprise product market.Developed by
Agfa formally introduced its medAr electronic patient record system at the European Congress of Radiology as part of the company’s strategy to move beyond the radiology industry and into the healthcare enterprise product market.
Developed by Quadrat, an Agfa-owned company headquartered in Sint-Martens-Latem, Belgium, medAr encompasses six separate modules: Medfile, for enterprise-wide result distribution; QPlanner for electronic ordering of exams and appointment scheduling; QPoli for clinical examination management and coding; QdReport for report generation; Billing Link for billing; and DRG for disease-related group statistics.
medAr has been installed in five sites in Belgium and is slated for installation in the 3500-bed hospital at the University of Montpellier, France. By the end of 2001, Agfa hopes to have 24 medAr installations completed.
The system is integrated with the Agfa RIS and PACS systems, allowing the assessment of images and patient data, according to Tom De Caluwé, Quadrat business development manager.
“It’s one of the advantages of the system in that it doesn’t have the linking problems you can find with other systems,” he said.
medAr was shown as a work-in-progress at the 2001 Healthcare Information and Management Systems Society conference in New Orleans. Agfa does not expect the system to be launched in the U.S. during 2001 but showed it at HIMSS to gain feedback from possible future customers and also to give attendees a chance to compare it with competing products from companies like Cerner and GE Medical. Agfa believes medAr’s data security features will meet the standards of the Health Insurance Portability and Accountability Act (HIPAA), although those have yet to be finalized.
“We are in a good position competitively, as our system was designed from the beginning as an integrated, enterprise-wide product,” Caluwé said. “Most of our competitors come from the result or nursing side and do not have the same smooth integration.”
medAr represents Agfa’s first step into the potentially huge, $40 billion enterprise products market, according to Caluwé.
“At the moment we are staying in Belgium and France, but we will be expanding,” he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
